MedTrace Logo

Efficacy and Safety of Transbronchial Bronchoscopic Thermal Vapor Ablation (BTVA) in Heterogeneous Emphysema

NCT06642038 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2024-10-15

No results posted yet for this study

Summary

Efficacy and Safety of Transbronchial BTVA in Heterogeneous Emphysema: A Prospective, Single-Arm, Multicenter Clinical Study

Conditions

  • Heterogeneous Emphysema

Interventions

PROCEDURE

Transbronchial Endoscopic Thermal Vapor Ablation

Transbronchial Endoscopic Thermal Vapor Ablation

Sponsors & Collaborators

  • Ruijin Hospital

    collaborator OTHER

  • First Hospital of China Medical University

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Shandong Provincial Public Health Clinical Center

    collaborator UNKNOWN

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Zhongda Hospital

    collaborator OTHER

  • Jiangxi Provincial People's Hopital

    collaborator OTHER

  • Shenzhen Baoan District People 's Hospital

    collaborator UNKNOWN

  • Fifth Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER

  • Ye Gu

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-13
Primary Completion
2025-09-01
Completion
2026-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06642038 on ClinicalTrials.gov